apomorphine has been researched along with pirenzepine in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 5 (38.46) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carrupt, PA; Crivori, P; Cruciani, G; Testa, B | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Bienkowski, P; Bucki, A; Jastrzębska-Więsek, M; Kazek, G; Kołaczkowski, M; Marcinkowska, M; Mierzejewski, P; Partyka, A; Pawłowski, M; Siwek, A; Śniecikowska, J; Wasik, A; Wesołowska, A | 1 |
| Axton, MS; Moore, NA; Risius, FC; Tye, NC | 1 |
| Chen, HY; Lee, EH; Lin, YP | 1 |
| Brianda, S; Delitala, G; Maioli, M; Mannelli, M; Pacifico, A; Palermo, M | 1 |
| Burger, JE; Czachura, JF; Gates, MR; Rasmussen, K | 1 |
| Kulkarni, SK; Ninan, I | 2 |
| Alper, RH; Gilliland, SL | 1 |
| Breese, GR; Knapp, DJ; Moy, SS | 1 |
| Ahnaou, A; Drinkenburg, WH; Megens, AA | 1 |
| Ago, Y; Kawasaki, T; Kobayashi, H; Koda, K; Matsuda, T; Takuma, K; Yano, K | 1 |
13 other study(ies) available for apomorphine and pirenzepine
| Article | Year |
|---|---|
Predicting blood-brain barrier permeation from three-dimensional molecular structure.
Topics: Blood-Brain Barrier; Databases, Factual; Models, Chemical; Molecular Conformation; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Novel 5-HT6 receptor antagonists/D2 receptor partial agonists targeting behavioral and psychological symptoms of dementia.
Topics: Animals; Benzamides; Dementia; Dose-Response Relationship, Drug; Drug Partial Agonism; Humans; Indoles; Ligands; Male; Models, Molecular; Molecular Structure; Piperazines; Quinolones; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Serotonin; Structure-Activity Relationship; Swimming | 2015 |
The behavioral pharmacology of olanzapine, a novel "atypical" antipsychotic agent.
Topics: Animals; Antipsychotic Agents; Apomorphine; Avoidance Learning; Benzodiazepines; Catalepsy; Conflict, Psychological; Discrimination Learning; Female; Male; Mice; Olanzapine; Pirenzepine; Rats; Rats, Inbred Strains | 1992 |
Cholinergic and GABAergic mediations of the effects of apomorphine on serotonin neurons.
Topics: Acetylcholine; Analysis of Variance; Animals; Apomorphine; Atropine; Bicuculline; Carbachol; gamma-Aminobutyric Acid; Hydroxyindoleacetic Acid; Male; Mecamylamine; Neurons; Pirenzepine; Raphe Nuclei; Rats; Rats, Inbred Strains; Serotonin; Tryptophan | 1992 |
Cholinergic receptor control mechanisms for L-dopa, apomorphine, and clonidine-induced growth hormone secretion in man.
Topics: Adult; Apomorphine; Benzodiazepinones; Clonidine; Growth Hormone; Humans; Kinetics; Levodopa; Male; Parasympatholytics; Pirenzepine; Prolactin; Receptors, Cholinergic | 1983 |
The novel atypical antipsychotic olanzapine, but not the CCK-B antagonist LY288513, blocks apomorphine-induced disruption of pre-pulse inhibition.
Topics: Acoustic Stimulation; Animals; Antipsychotic Agents; Apomorphine; Benzodiazepines; Dose-Response Relationship, Drug; Hormone Antagonists; Male; Olanzapine; Pirenzepine; Pyrazoles; Rats; Reflex, Startle | 1997 |
Preferential inhibition of dizocilpine-induced hyperlocomotion by olanzapine.
Topics: Animals; Antipsychotic Agents; Apomorphine; Benzodiazepines; Catalepsy; Dizocilpine Maleate; Dopamine Agonists; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Locomotion; Male; Mice; Mice, Inbred BALB C; Motor Activity; Olanzapine; Pirenzepine; Stereotyped Behavior; Stereotypic Movement Disorder | 1999 |
Antagonism by pimozide of olanzapine-induced hypothermia.
Topics: Animals; Antipsychotic Agents; Apomorphine; Azepines; Benzazepines; Benzodiazepines; Body Temperature; Dopamine Agonists; Dopamine Antagonists; Hypothermia; Male; Olanzapine; Pimozide; Pirenzepine; Rats; Rats, Wistar | 1999 |
Characterization of dopaminergic compounds at hD2short, hD4.2 and hD4.7 receptors in agonist-stimulated [35S]GTPgammaS binding assays.
Topics: Animals; Apomorphine; Benzodiazepines; Binding, Competitive; CHO Cells; Clozapine; Cricetinae; Dopamine Agonists; Dopamine Antagonists; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Olanzapine; Pirenzepine; Radioligand Assay; Receptors, Dopamine; Selective Serotonin Reuptake Inhibitors; Sulfur Radioisotopes; Transfection | 2000 |
Effect of olanzapine on functional responses from sensitized D1-dopamine receptors in rats with neonatal dopamine loss.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adrenergic Agents; Animals; Animals, Newborn; Antipsychotic Agents; Apomorphine; Benzodiazepines; Corpus Striatum; Dopamine; Dopamine Agonists; Female; Male; Motor Activity; Olanzapine; Oxidopamine; Pirenzepine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1 | 2001 |
The atypical antipsychotics risperidone, clozapine and olanzapine differ regarding their sedative potency in rats.
Topics: Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Benzodiazepines; Clozapine; Conscious Sedation; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Combinations; Electroencephalography; Fourier Analysis; Hypnotics and Sedatives; Male; Olanzapine; Pirenzepine; Rats; Rats, Wistar; Risperidone; Stereotyped Behavior; Time Factors | 2003 |
Galantamine improves apomorphine-induced deficits in prepulse inhibition via muscarinic ACh receptors in mice.
Topics: Acetylcholine; Acoustic Stimulation; Animals; Animals, Outbred Strains; Apomorphine; Behavior, Animal; Benzazepines; Cholinesterase Inhibitors; Donepezil; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Galantamine; Indans; Inhibition, Psychological; Male; Mecamylamine; Mice; Microdialysis; Muscarinic Agonists; Muscarinic Antagonists; Nicotinic Antagonists; Oxotremorine; Piperidines; Pirenzepine; Prefrontal Cortex; Receptors, Muscarinic; Reflex, Startle; Serotonin | 2009 |